M

MHRA

Regulates medicines and medical devices

Overview

MHRA is a government agency in the UK that regulates medicines and medical devices to protect public health. It ensures medicines and devices meet safety and quality standards before they are sold, and it monitors them after they reach the market. The agency operates through three parts: the regulatory centre, which reviews medicines and devices; the National Institute for Biological Standards and Control (NIBSC), which develops and validates biological standards and tests; and the Clinical Practice Research Datalink (CPRD), which collects real-world health data for research to improve care. Unlike private companies that make or sell medical products, MHRA focuses on safety, effectiveness, and quality for the public, and shares findings with manufacturers, clinicians, and the public. Its goal is to enhance and protect the health of millions by making sure medicines and medical devices are safe and effective.”}{

Work here?Claim your company

About MHRA

Simplify's Rating
Why MHRA is rated
B
Rated A on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsGovernment & Public SectorAI & Machine LearningHealthcare

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

United Kingdom

Founded

1989

Get referred to MHRA

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • MHRA secured £3.6 million for AI Airlock, expanding regulated AI medical device testing.
  • New clinical trials regulations launch 2026, including 14-day phase one assessments and faster approvals.
  • MHRA-NICE aligned pathway aims to cut patient access timelines by up to six months.

What critics are saying

  • November 17, 2026 Westminster Hall debate targets MHRA over patient safety and transparency.
  • The Yellow Card scheme faces criticism in the 2026 Covid-19 Inquiry module four report.
  • November 13, 2026 Microsoft outage disrupted MHRA email services, exposing fragile operational dependence.

What makes MHRA unique

  • MHRA approved 921 medicines in 2025-26, including 39 new medicines, at target speed.
  • MHRA Strategy 2030, launched October 14, 2026, centers patient safety and faster access.
  • WHO Listed Authority status and ACCESS consortium leadership strengthen MHRA’s global regulatory credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Hybrid Work Options
  • Remote Work Options

Company News

HoldtheFrontPage.co.uk Limited
Nov 5th, 2026
$7.6M government fund backs 50 local news providers with grants of up to $159,000

The government has named the first 50 recipients of its £6m Local News Fund, with grants of up to £125,000 each. They range from large publishers to small hyperlocal startups. Seven organisations also won up to £275,000 each to build infrastructure for the wider industry. The NCTJ gets £191,000 to promote responsible use of AI, and Media Concierge gets £239,960 to expand its Minerva data platform. Mill Media receives £125,000 for a reader data platform. Newsquest gets £125,000 to pilot a hyperlocal service for Hammersmith & Fulham. A second £6m round is due next year, with £1m set aside for news deserts. Steering Board co-chair Jeremy Clifford said many good bids were turned down and urged ministers to find more funding.

2b Publishing
Nov 2nd, 2026
SaxaVord secures $76.2M public-private deal to finish Shetland spaceport launchpads

SaxaVord has finalised a £60 million public-private funding deal to complete launch infrastructure at its spaceport at Lamba Ness on Unst, Shetland. The UK Government is contributing £30 million, matched by long-standing investor Wild Ventures. The money will pay for three launchpads, mission management infrastructure, and a second integration hangar. The government first outlined its investment in September, subject to due diligence and final approval. Wild Ventures, an investment arm of Heartland, may let other investors take part in its commitment. SaxaVord is approved for up to 30 launches a year. Germany's Rocket Factory Augsburg is working towards an orbital test flight, while HyImpulse targets spring 2027 for its first suborbital flight.

Kalkine Media
Oct 29th, 2026
UK to give Rolls-Royce up to $1.6B for UltraFan engine as it plans $3.2B investment

Rolls-Royce will receive up to 1.25 billion in UK government support to develop and build its UltraFan engine in Britain. The engine targets the short-haul aircraft market. The company plans to invest 2.5 billion in the programme over the next decade. It also intends to create 3,300 UK roles by 2029. Public funding does not remove technical and commercial risks. The engine must still meet performance, reliability and certification requirements, and win customers. Rolls-Royce's civil aerospace and Power Systems businesses remain central to its growth. Cost control, supply chain pressure and cash generation will shape the returns.

Tech Funding News
Oct 26th, 2026
UK adds $152M to Sovereign AI Fund and procurement scheme to back and buy from startups

HM Treasury is adding £120 million to the UK's Sovereign AI Fund, which backs domestic AI startups. Half will go into direct investments in UK AI companies, and half into the Sovereign AI R&D Procurement Scheme. The Fund rises to £560 million, and the procurement scheme grows from £100 million to £160 million. The Fund now also targets physical and industrial AI, including robotics, autonomous systems, and advanced manufacturing. Under the scheme, the government acts as an early customer rather than a grant funder. Firms build the technology, departments trial it, and successful firms keep their IP. The money is part of a £621 million AI package announced on October 24, days before the Chancellor's Budget on October 28.

Bloomberg
Oct 23rd, 2026
UK commits $127M to AI biosecurity lab backed by OpenAI, Anthropic and Google DeepMind

The UK has announced £100 million ($134 million) for an AI Biosecurity Lab, which OpenAI, Anthropic, and Google DeepMind will support. The funding is part of a package of measures to help the government understand and tackle the risks posed by the technology.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for MHRA right now.

Find jobs on Simplify and start your career today

We update MHRA's jobs every few hours, so check again soon!Browse all jobs